“Successful Treatment of Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma in a Child with Modified Dose-Adjusted EPOCH Chemotherapy and Reduced-Intensity Hematopoietic Stem Cell Transplant”

https://pubmed.ncbi.nlm.nih.gov/38117087

A child with systemic Epstein-Barr virus-positive T-cell lymphoma was successfully treated with a modified dose-adjusted EPOCH chemotherapy regimen followed by reduced-intensity hematopoietic stem cell transplant, providing a potential alternative treatment approach for this rare and aggressive disease.